A shadow economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Investigational Drug Gaining Traction Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are urged to contact these profiles directly for supplier links, while also obtaining discount codes.
Thriving Trade on Social Networks
Separately, a robust market exists on messaging services, where groups with thousands of members share comparison photos, injection guides and assertions of rapid British shipping. Sellers promote the substance there before redirecting customers to other platforms for transactions.
Learning About Retatrutide
This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users injecting products of uncertain source.
Several professionals stated the demand for retatrutide could be connected to the rising cost of approved weight loss products such as Mounjaro.
Regulatory Status and Implementation
Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and customer laws, risking fines, legal action or prison.
Service Response and Material Removal
According to TikTok, the service has taken down violative content and banned associated hashtags and query recommendations. The organization stated it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Digital Trading Activities
Investigations also discovered communities with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, populated with photos of weight loss, positive testimonials and detailed instructions for preparing or injecting at residence.
After moments of joining one community, a vendor posted WhatsApp details, where most transactions occur. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, medical conditions or past usage.
Product Information and Pricing
Inside these groups, messages show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with sterile water, or pre-filled pens typically sold at £160 for 20mg. When questioned how long a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for Telegram stated it actively monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting substances they can’t verify. Even if the science behind retatrutide is valid, these online versions may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.
Her staff has previously encountered individuals harmed by personal administration from unverified suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose patients to possibly significant medical dangers”.
